Hyponatremia (serum sodium <135 mEq/L) is the most common electrolyte disorder, affecting ~5% of adults and up to 35% of hospitalized patients. [1] It most commonly results from water retention and is classified by severity as mild (130–134), moderate (125–129), or severe (<125 mEq/L). [2] The following is a comprehensive clinical summary organized for emergency medicine and primary care practice.
The following diagnostic algorithm illustrates the systematic approach to evaluating hypotonic hyponatremia based on volume status, urine sodium, and urine osmolality:
1. History
- Onset and duration: Acute (<48 hours) vs. chronic (≥48 hours or unknown) — this distinction is critical for treatment intensity and risk of osmotic demyelination [1-2]
- Fluid intake: Excessive water intake (polydipsia, endurance exercise, ecstasy use), beer potomania, tea-and-toast diet [2]
- Fluid losses: Vomiting, diarrhea, excessive sweating, blood loss [1]
- Medication review: Recent initiation or dose changes of thiazides, SSRIs/SNRIs, carbamazepine, oxcarbazepine, opioids, desmopressin, antipsychotics [1-3]
- Surgical history: Postoperative state is a common trigger for acute hyponatremia [1]
- Weight changes: Recent gain (hypervolemic) vs. loss (hypovolemic)
- Symptom characterization: Weakness, nausea, headache (mild) → vomiting, confusion (moderate) → somnolence, seizures, respiratory distress (severe) [1]
- Past episodes of hyponatremia and prior sodium levels
2. Alarm Features
- Seizures, somnolence, obtundation, coma — indicate hyponatremic encephalopathy requiring emergency treatment [1]
- Cardiorespiratory distress — noncardiogenic pulmonary edema can occur with acute water intoxication [1]
- Rapidly progressive symptoms — can deteriorate suddenly to brain herniation and respiratory arrest [1]
- Na <125 mEq/L with any neurological symptoms — warrants immediate intervention [2]
- Premenopausal women and prepubertal children — at higher risk of severe cerebral edema and poor outcomes from acute hyponatremia [4]
- Postoperative patients or those with intracranial pathology — even moderate symptoms warrant urgent treatment due to risk of catastrophic cerebral edema [5]
3. Medications
Common culprits: [1-3]
- Thiazide diuretics — #1 cause of drug-induced hyponatremia; risk highest in first weeks, especially in elderly, low-BMI women; up to 30% of patients affected
- SSRIs/SNRIs — induce SIAD in up to 32% of patients; duloxetine and escitalopram carry highest risk; bupropion and paroxetine lowest [6]
- Carbamazepine/oxcarbazepine — highest incidence among anticonvulsants [7]
- Antipsychotics (clozapine, haloperidol), opioids, desmopressin, oxytocin
- Antineoplastics: vincristine, ifosfamide, cisplatin, cyclophosphamide
- Others: TCAs, NSAIDs, ACE inhibitors, PPIs, ecstasy (MDMA)
- Immune checkpoint inhibitors — can cause hypophysitis/adrenalitis leading to cortisol deficiency and hyponatremia [3]
Treatments by volume status: [2]
- Hypovolemic → normal saline + treat underlying cause
- Euvolemic (SIAD) → fluid restriction (500 mL–1 L/day), salt tablets, oral urea, or tolvaptan
- Hypervolemic → fluid restriction, treat underlying cause (CHF, cirrhosis), consider urea or vaptans
Contraindicated: Hypotonic fluids in all symptomatic patients; tolvaptan in liver disease (hepatotoxicity risk)
4. Diet
- Low-solute diets (tea-and-toast, beer potomania) impair free water excretion and predispose to hyponatremia [1-2]
- Adequate salt and protein intake is recommended, particularly in chronic SIAD [8-9]
- Fluid restriction is the cornerstone of euvolemic and hypervolemic hyponatremia management: 500 mL–1 L/day [2][8]
- In hypervolemic hyponatremia with heart failure, increasing dietary sodium may be considered alongside fluid restriction [2]
5. Review of Systems
- Neurological: Headache, confusion, lethargy, gait instability, falls, cognitive deficits, seizures [1]
- GI: Nausea, vomiting (both a symptom and a cause via volume depletion)
- Pulmonary: Cough, dyspnea (pneumonia as cause of SIAD; noncardiogenic pulmonary edema as complication) [1]
- Cardiovascular: Edema, orthopnea, PND (heart failure as cause)
- Endocrine: Fatigue, weight changes (hypothyroidism, adrenal insufficiency)
- Musculoskeletal: Muscle cramps, weakness
- Psychiatric: Psychosis, depression (polydipsia in schizophrenia; psychotropic medications as cause) [10]
6. Collateral History and Family History
- Collateral: Confirm fluid intake patterns, medication adherence, alcohol use, illicit drug use (ecstasy), recent exercise habits [2]
- Psychiatric history: Schizophrenia (psychogenic polydipsia), depression (SSRI use)
- Family history: Rarely relevant; nephrogenic SIAD from gain-of-function V2 receptor variants is exceedingly rare [1]
- Social context: Living situation (access to food/water), alcohol use disorder (major risk factor for ODS) [1]
7. Risk Factors
- Advanced age (>65 years) — impaired aquaresis, polypharmacy, low solute intake [5]
- Female sex — especially premenopausal women (higher risk of cerebral edema) and elderly women on thiazides/SSRIs [1]
- Low body mass index [1]
- Medications — thiazides, SSRIs, carbamazepine (see above)
- Comorbidities: Heart failure, cirrhosis, CKD, cancer, pulmonary disease, HIV/AIDS [1-2]
- Alcohol use disorder — both a cause (beer potomania) and a risk factor for ODS [1]
- Malnutrition — risk factor for ODS [1-2]
- Postoperative state, endurance exercise, severe nausea/pain [1]
8. Differential Diagnosis
The key first step is distinguishing hypotonic from nonhypotonic hyponatremia: [1][11]
- Pseudohyponatremia (isotonic): Severe hyperproteinemia, extreme hyperlipidemia — normal tonicity, lab artifact [1]
- Hypertonic hyponatremia: Hyperglycemia (each 100 mg/dL glucose rise decreases Na by ~2 mEq/L), mannitol, contrast media [1]
- Hypotonic hyponatremia — further classified by volume status:
- Hypovolemic: GI losses, diuretics, adrenal insufficiency, cerebral salt wasting, burns, hemorrhage [1]
- Euvolemic: SIAD (most common — cancer, drugs, pulmonary/CNS disease), hypothyroidism, glucocorticoid deficiency, primary polydipsia, low solute intake [1][5]
- Hypervolemic: Heart failure, cirrhosis, nephrotic syndrome, CKD [1]
Cannot-miss diagnoses: Adrenal crisis (Addison disease — hyponatremia + hyperkalemia), subarachnoid hemorrhage with cerebral salt wasting, occult malignancy causing SIAD [1][5]
9. Past Medical History
- Prior episodes of hyponatremia and documented nadir sodium levels
- Heart failure, cirrhosis, CKD, nephrotic syndrome (hypervolemic causes)
- Cancer history (SIAD from malignancy — lung, head/neck, GI, GU) [5]
- Psychiatric illness (polydipsia, psychotropic medications)
- Endocrine disorders: Hypothyroidism, adrenal insufficiency, pituitary disease
- Alcohol use disorder, malnutrition (ODS risk factors) [1]
- Surgical history: Recent procedures (postoperative hyponatremia)
- Liver transplant history (high ODS risk) [12]
10. Physical Exam
- Vital signs: Hypotension/tachycardia (hypovolemia), hypertension (hypervolemia)
- Volume status assessment — though sensitivity (50–70%) and specificity (30–50%) are limited: [1]
- Hypovolemia: Dry mucous membranes, poor skin turgor, orthostatic hypotension, flat JVP
- Euvolemia: No edema, no signs of dehydration
- Hypervolemia: Peripheral edema, ascites, JVD, pulmonary crackles
- Neurological exam: Mental status (GCS), orientation, gait assessment, reflexes, signs of increased ICP (papilledema)
- Stigmata of liver disease: Jaundice, spider angiomata, palmar erythema, ascites
- Signs of heart failure: S3 gallop, elevated JVP, bilateral crackles
- Thyroid exam: Goiter or signs of myxedema
- Skin: Hyperpigmentation (Addison disease)
11. Lab Studies
Initial workup: [1-2]
- Serum sodium (confirm on BMP/CMP)
- Serum osmolality — distinguishes hypotonic (<275 mOsm/kg) from isotonic/hypertonic
- Urine osmolality — >100 mOsm/kg suggests impaired water excretion (SIAD, volume depletion); <100 mOsm/kg suggests primary polydipsia or low solute intake
- Urine sodium — >30 mEq/L suggests renal losses or SIAD; <30 mEq/L suggests extrarenal losses or edematous states
- BUN, creatinine — elevated in hypovolemia; low BUN in SIAD
- Serum uric acid — low in SIAD, elevated in hypovolemia
- Glucose — rule out hyperglycemic hyponatremia
Additional labs based on clinical suspicion: [1][5]
- TSH, free T4 — rule out severe hypothyroidism
- Morning cortisol ± ACTH — rule out adrenal insufficiency (required before diagnosing SIAD)
- BNP — if heart failure suspected
- Lipid panel, serum protein — if pseudohyponatremia suspected
- Potassium — concurrent hypokalemia increases ODS risk and suggests Addison disease if hyperkalemic [1]
- LFTs — liver disease assessment
Monitoring during treatment: [2]
- Check sodium after each hypertonic saline bolus
- Then every 4–6 hours during the first 24 hours
12. Imaging
- Chest X-ray: If pulmonary cause of SIAD suspected (pneumonia, lung mass) or to evaluate for pulmonary edema/heart failure [5]
- CT head: If intracranial pathology suspected (SAH, mass, trauma) or if SIAD etiology unclear [5]
- CT chest/abdomen/pelvis: Consider if SIAD etiology undetermined after initial workup — to evaluate for occult malignancy [5]
- Brain MRI: Not needed acutely; used 2–4 weeks after overcorrection to evaluate for osmotic demyelination (hyperintense T2 lesions in pons/extrapontine structures) [1]
- Imaging is unnecessary for mild hyponatremia with a clear medication-related or dietary cause
13. Special Tests
- Fractional excretion of uric acid (FEUrate): Elevated (>12%) in SIAD; may help distinguish from hypovolemic hyponatremia [11][13]
- Plasma copeptin: Emerging biomarker that may improve diagnostic accuracy for SIAD [11]
- Point-of-care sodium: Not subject to pseudohyponatremia artifact from hyperproteinemia/hyperlipidemia [1]
- Saline infusion test: Response to isotonic saline can help differentiate hypovolemic from euvolemic hyponatremia when clinical assessment is uncertain
14. ECG
- Hyponatremia alone does not produce classic, reliable ECG changes like hypo/hyperkalemia [14]
- Severe hyponatremia (<120 mEq/L) has been reported to cause:
- Brugada-like pattern (coved ST elevation in V1–V3) due to reduced inward sodium current — resolves with sodium correction [15-16]
- AV conduction defects (second-degree or complete heart block), particularly in patients with underlying cardiac disease [17]
- ECG is indicated to evaluate for concurrent electrolyte abnormalities (hypokalemia, hypomagnesemia) and underlying cardiac disease
- Always check for QTc prolongation from concurrent medications or electrolyte derangements
15. Assessment
Severity classification: [2]
- Mild (130–134 mEq/L): Often asymptomatic or nonspecific symptoms; still associated with increased falls, fractures, and mortality [1]
- Moderate (125–129 mEq/L): Nausea, headache, mild cognitive deficits
- Severe (<125 mEq/L): Confusion, seizures, coma — medical emergency
Acuity matters more than absolute number: Acute hyponatremia (<48 hours) is more dangerous than chronic, even at the same sodium level, because the brain has not yet adapted. [1] Chronic hyponatremia carries higher risk of osmotic demyelination with rapid correction. [1]
Complications: Cerebral edema, brain herniation, respiratory arrest, permanent brain damage, osmotic demyelination syndrome (from overcorrection), chronic gait instability, osteoporosis, and fractures [1]
16. Treatment Plan
Severely symptomatic (seizures, coma, respiratory distress) — regardless of duration: [1-2][5]
- 3% hypertonic saline: 100 mL IV bolus over 10 minutes (US guideline) or 150 mL over 20 minutes (European guideline)
- Repeat up to 2–3 times until symptoms improve
- Goal: Raise sodium by 4–6 mEq/L within 1–2 hours — sufficient to reverse cerebral edema
- Withhold all hypotonic fluids and offending medications immediately
Correction limits: [1-2][18]
A recent meta-analysis (2025) of 16 cohort studies (n=11,811) found that rapid correction (≥8–10 mEq/L/24h) was associated with 32 fewer in-hospital deaths per 1,000 compared with slow correction, without a statistically significant increase in ODS. [19] This has prompted some experts to reconsider overly conservative correction limits, though current guidelines remain in place.
If overcorrection occurs: [2][18]
- Stop all sodium-raising therapies
- Administer D5W at 3 mL/kg/hr
- Consider desmopressin (DDAVP) 2–4 mcg IV to halt free water excretion
Non-severe hyponatremia by volume status: [2]
- Hypovolemic: Normal saline + treat underlying cause (stop diuretics, replace GI losses)
- Euvolemic (SIAD): Fluid restriction 500 mL–1 L/day; second-line: salt tablets + furosemide, oral urea (30–60 g/day), or tolvaptan (15 mg daily, initiate in hospital only)
- Hypervolemic: Fluid restriction 1 L/day, optimize heart failure/cirrhosis management; consider urea or vaptans
17. Disposition
Admit (ICU): [1-2]
- Na <125 mEq/L with severe symptoms (seizures, altered consciousness, respiratory distress)
- Any patient requiring hypertonic saline
- Acute hyponatremia with neurological symptoms
Admit (floor/observation): [2]
- Na <125 mEq/L with mild-moderate symptoms
- Na <120 mEq/L regardless of symptoms
- High-risk comorbidities: heart disease, alcoholism, malnutrition, liver disease, active pulmonary disease
- New-onset hyponatremia requiring etiologic workup
Discharge considerations
- Mild hyponatremia (130–134 mEq/L) with clear, reversible cause (e.g., thiazide recently started) and no significant symptoms
- Chronic stable mild hyponatremia with outpatient follow-up arranged
Consult nephrology or endocrinology for refractory SIAD, unclear etiology, severe hyponatremia, or overcorrection concerns [5]
18. Follow Up / Return Precautions
- Recheck sodium within 24–48 hours after discharge if medication was adjusted or cause was recently addressed
- Weekly sodium monitoring for 2–4 weeks after starting or stopping a causative medication [10]
- Return immediately for: confusion, severe headache, seizures, persistent vomiting, difficulty walking, excessive drowsiness
- Chronic hyponatremia follow-up: Monitor for gait instability, falls, cognitive changes, and osteoporosis — hyponatremia is a secondary cause of osteoporosis [1]
- Medication reconciliation: Ensure offending agents remain discontinued; if rechallenge is necessary, monitor sodium closely
- Patient counseling: Educate on fluid restriction adherence, adequate dietary salt/protein intake, and avoidance of excessive free water intake [8]
- Expected course: Mild medication-induced hyponatremia typically resolves within days of drug discontinuation; SIAD from malignancy may require ongoing management
References
1. Diagnosis and Management of Hyponatremia: A Review. — Adrogué HJ, Tucker BM, Madias NE. The Journal of the American Medical Association. 2022.
2. Diagnosis and Management of Sodium Disorders: Hyponatremia and Hypernatremia. — Miller NE, Rushlow D, Stacey SK. American Family Physician. 2023.
3. Drug-Induced Hyponatremia in Clinical Care. — Mannheimer B, Lindh JD, Fahlén CB, et al. European Journal of Internal Medicine. 2025.
4. Treatment of Hyponatremic Encephalopathy in the Critically Ill. — Achinger SG, Ayus JC. Critical Care Medicine. 2017.
5. The Syndrome of Inappropriate Antidiuresis. — Adrogué HJ, Madias NE. The New England Journal of Medicine. 2023.
6. Hyponatremia Associated With the Use of Common Antidepressants in the All of Us Research Program. — Mo H, Channa Y, Ferrara TM, et al. Clinical Pharmacology and Therapeutics. 2025.
7. Psychotropic Drug-Induced Hyponatremia: Results From a Drug Surveillance Program-an Update. — Seifert J, Letmaier M, Greiner T, et al. Journal of Neural Transmission. 2021.
8. Hyponatraemia-Treatment Standard 2024. — Spasovski G. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 2024.
9. Treatment of Chronic Hyponatremia and Controversy About Osmotic Demyelination Syndrome. — Beck J. Best Practice & Research. Clinical Endocrinology & Metabolism. 2025.
10. Management of SIADH-related Hyponatremia Due to Psychotropic Medications - An Expert Consensus From the Association of Medicine and Psychiatry. — Pinkhasov A, Xiong G, Bourgeois JA, et al. Journal of Psychosomatic Research. 2021.
11. Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. — Hoorn EJ, Zietse R. Journal of the American Society of Nephrology : JASN. 2017.
12. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. — Biggins SW, Angeli P, Garcia-Tsao G, et al. Hepatology. 2021.
13. Diagnostic Algorithm of Hyponatremia. — Lin R, Grossmann M, Warren AM. Best Practice & Research. Clinical Endocrinology & Metabolism. 2025.
14. Electrocardiographic Manifestations: Electrolyte Abnormalities. — Diercks DB, Shumaik GM, Harrigan RA, Brady WJ, Chan TC. The Journal of Emergency Medicine. 2004.
15. Brugada-Like Electrocardiography Pattern Induced by Severe Hyponatraemia. — Tamene A, Sattiraju S, Wang K, Benditt DG. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2010.
16. Brugada Type 1 Electrocardiographic Pattern Induced by Severe Hyponatremia. — Alvarez PA, Vázquez Blanco M, Lerman J. Cardiology. 2011.
17. Cardiac Conduction Defects Associated With Hyponatremia. — Mouallem M, Friedman E, Shemesh Y, et al. Clinical Cardiology. 1991.
18. The Treatment of Acute Symptomatic Hyponatraemia in the Hospital Setting. — Prince R, Chifu I, Arshad MF. Best Practice & Research. Clinical Endocrinology & Metabolism. 2025.
19. Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia: A Systematic Review and Meta-Analysis. — Ayus JC, Moritz ML, Fuentes NA, et al. JAMA Internal Medicine. 2025.